Kidney disease in diabetology: lessons from 2008.
Schernthaner
Guntram
G
Head of the Department of Medicine I, Rudolfstiftung Hospital-Vienna, Juchgasse 25, A - 1030 Vienna, Austria. guntram.schernthaner@meduniwien.ac.at
D000328:Adult; D000419:Albuminuria / Q000150:complications / Q000517:prevention & control / Q000628:therapy; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002648:Child; D002986:Clinical Trials as Topic; D048909:Diabetes Complications / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D003928:Diabetic Nephropathies / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D012084:Renin-Angiotensin System / Q000187:drug effects
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D001786:Blood Glucose